Languages
Pages
Legal
Explore all categories to find your favorite topic
8/2/2019 Comparison of CABG With Drug Eluting Stent 1/10. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .…
Présentation PowerPointdual antiplatelet therapy duration. A pre-specified analysis from the The Zotarolimus- eluting Endeavor sprint stent in Uncertain DES candidates
PowerPoint Presentation USA â CANADA â UK â CHINA â INDIA Global Drug-Eluting Stent Market 2016-2020 USA â CANADA â UK â CHINA â INDIA Scope of The Report Market…
Clinically proven Highly deliverable The new benchmark for DES In a post-hoc analysis of pooled patient-level data from three RCTs, Orsiro achieved a 96.9% probability of
1. Endeavor IV: A Randomized Comparison of a Zotarolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease Martin B. Leon, MDColumbia…
Biolimus-A9™ Eluting Stent Biolimus is a semi-synthetic sirolimus analogue with 10x higher lipophilicity and similar potency as sirolimus. Biolimus is immersed at a…
Slide 1 Slide 2 BIOLIMUS-ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS-ELUTING STENT WITH DURABLE POLYMER: A RANDOMISED, NON-INFERIORITY TRIAL Stephan Windecker,…
Giuseppe Biondi-Zoccai, MD San Raffaele Hospital EMO Centro Cuore Columbus Milan, Italy on behalf of the RECIPE Investigators INCIDENCE AND OUTCOME OF CORONARY DISSECTIONS…
Slide 1 Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous coronary…
Patient Information Guide Everolimus Eluting Coronary Stent System 33 Coronary Artery Disease (CAD) ........................5 Your Heart ........................................................5…
RESEARCH ARTICLE Open Access Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review…
1. EuroSTAR IIThe European RandomizedCoStar ™Trial: Cobalt-Chromium Paclitaxel-eluting Stent vs. identical BMS Sigmund Silber, MD, FACC, FESC Cardiology Practice and Hospital…
Vol: 3 No: 1; 2007 "Insight Heart" is also available at www.squarepharma.com.bd Cardiology News Attenuated Coronary Collateral Function After Drug-Eluting Stent…
INSTRUCTIONS FOR USE CAUTION - Federal (USA) law restricts this device for sale by or on the order of a physician. 97 Table of Contents I RESOLUTE INTEGRITY ZOTAROLIMUS ELUTING
untitledNew Tokyo Circulation Research Group Drug Eluting Stent Implantation For Unprotected Left Main Coronary Arteries Arteries Angioplasty Summit Seoul 1. Park SJ, Kim
Slide 1SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease One Year Clinical…
Prior Authorization Review Panel MCO Policy Submission A separate copy of this form must accompany each policy submitted for review Policies submitted without this form will…
TWENTE-I, 5 Years, TCT 2015 TWENTE A Prospective Randomized Trial of a Durable-Polymer Zotarolimus-Eluting Stent Versus a Durable-Polymer Everolimus-Eluting Stent in Patients…
Slide 1DESERT (Drug-Eluting Stent Event Registry of Thrombosis) DESERT (Drug-Eluting Stent Event Registry of Thrombosis) The International FDA approved DES Thrombosis Registry…
SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease One Year Clinical…